You have 9 free searches left this month | for more free features.

pf-00489791

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypertension Trial in United States (, PF-00489791)

Completed
  • Hypertension
  • placebo
  • PF-00489791
  • Los Angeles, California
  • +19 more
Sep 13, 2021

Raynaud's Disease, Peripheral Vascular Disease Trial in Worldwide (PF-00489791)

Completed
  • Raynaud's Disease
  • Peripheral Vascular Disease
  • PF-00489791
  • Redwood City, California
  • +54 more
Apr 16, 2018

Diabetic Nephropathies Trial in Worldwide (PF-00489791, Placebo)

Completed
  • Diabetic Nephropathies
  • PF-00489791
  • Placebo
  • Huntsville, Alabama
  • +159 more
Feb 18, 2019

Hypertension, Pulmonary Trial in Worldwide (PF-00489791, , sildenafil)

Terminated
  • Hypertension, Pulmonary
  • PF-00489791
  • +2 more
  • Phoenix, Arizona
  • +24 more
Sep 20, 2017

Healthy Volunteers Trial in Brussels (itraconazole, diltiazem, SR verapamil)

Completed
  • Healthy Volunteers
  • Brussels, Belgium
    Pfizer Clinical Research Unit
Jul 28, 2016